TrialScientific reports2024
Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.
Amy D Harper et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled ittrialcites it